ConductScience.org, home

Paper495489

Effects of nifedipine after intravenous and intracoronary administration.

Kaltenbach M and 2 others. Am J Cardiol, 1979. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Effects of nifedipine after intravenous and intracoronary administration. Papers, record 495489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/495489

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of nifedipine after intravenous and intracoronary administration.
PubMed
Journal
Am J Cardiol
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
6.19
iCite
Revised in PubMed
2019-06-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaltenbach MM
2Schulz WW
3Kober GG

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NifedipineMajor topic
PyridinesMajor topic
Aged
Angina Pectoris
Angina Pectoris, Variant
Coronary Circulation
Coronary Vessels
Dose-Response Relationship, Drug
Hemodynamics
Humans
Injections, Intra-Arterial
Injections, Intravenous
Male
Middle Aged
Myocardial Contraction
Spasm

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
10529079Coronary artery vasomotion and post-stenotic coronary artery blood flow after intracoronary lacidipine in patients with ischaemic heart disease: a pilot study.Drugs1999https://conductscience.org/library/papers/10529079PubMed
9034752Coronary endothelial function in health and disease.Drugs1997https://conductscience.org/library/papers/9034752PubMed
7073651Intracoronary infusion of small doses of nifedipine lowers regional myocardial O2-consumption without altering regional myocardial function.Basic Res Cardiol1982https://conductscience.org/library/papers/7073651PubMed
7032554Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.Br Heart J1981https://conductscience.org/library/papers/7032554PubMed
7023517Role of calcium antagonists in cardiovascular therapy.Br Heart J1981https://conductscience.org/library/papers/7023517PubMed
6838731Influence of intracoronary nifedipine on left ventricular function, coronary vasomotility, and myocardial oxygen consumption.Br Heart J1983https://conductscience.org/library/papers/6838731PubMed
6743423Beneficial effects of diltiazem in coronary artery disease.Br Heart J1984https://conductscience.org/library/papers/6743423PubMed
6466517Alterations in angina threshold with nifedipine during pacing induced angina.Br Heart J1984https://conductscience.org/library/papers/6466517PubMed
6112981Calcium antagonists: definition and mode of action.Basic Res Cardiol1981https://conductscience.org/library/papers/6112981PubMed
3831030Modification of pacing-induced alterations in diastolic properties of the regional myocardium by nifedipine in patients with coronary artery disease.Heart Vessels1985https://conductscience.org/library/papers/3831030PubMed
3784463[Calcium antagonists in heart failure?].Klin Wochenschr1986https://conductscience.org/library/papers/3784463PubMed
3327697
Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial.
Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3327697PubMed
2908712The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/2908712PubMed
2875727Combination therapy with beta-adrenoceptor blockers and calcium antagonists.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2875727PubMed
2874975The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.Drugs1986https://conductscience.org/library/papers/2874975PubMed
2412780Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.Drugs1985https://conductscience.org/library/papers/2412780PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/495489

GET https://conductscience.org/api/papers/v1/495489/authors